Category Press Releases

Acadia

Acadia Pharmaceuticals Announces Year-End Retirement of R&D Head Elizabeth H.Z. Thompson, Ph.D.

Acadia Pharmaceuticals Plans Year-End Retirement of R&D Chief Elizabeth H.Z. Thompson After Distinguished Career Acadia Pharmaceuticals Inc. has announced that Elizabeth H.Z. Thompson, Ph.D., its Head of Research and Development, plans to retire from her role for personal reasons. The…

Read MoreAcadia Pharmaceuticals Announces Year-End Retirement of R&D Head Elizabeth H.Z. Thompson, Ph.D.

Curocell’s RIMQARTO Injection Secures Full Regulatory Approval, Set to Enter CAR-T Market with 67% Complete Response Rate

Curocell’s RIMQARTO Injection Secures Full Regulatory Approval, Positioned to Enter CAR-T Market with 67% Complete Response Rate South Korean biotechnology company Curocell (KOSDAQ: 372320) has achieved a landmark milestone in the nation’s advanced therapeutics landscape with the full regulatory approval…

Read MoreCurocell’s RIMQARTO Injection Secures Full Regulatory Approval, Set to Enter CAR-T Market with 67% Complete Response Rate

Cosette Pharmaceuticals Names Erika Tooman SVP & General Counsel to Support Growth Strategy

Cosette Pharmaceuticals Names Erika Tooman as Senior Vice President and General Counsel, Enhancing Leadership to Support Growth and Strategic Expansion Cosette Pharmaceuticals, a U.S.-based branded specialty pharmaceutical company, has announced the appointment of Erika Tooman as Senior Vice President and…

Read MoreCosette Pharmaceuticals Names Erika Tooman SVP & General Counsel to Support Growth Strategy

Masimo SET® Pulse Oximetry Shows Accurate Performance Across All Newborn Skin Tones in Landmark Study

Masimo SET® Pulse Oximetry Demonstrates Consistent Accuracy Across All Newborn Skin Tones in Largest-Ever Real-World Prospective Study Masimo has announced new clinical findings that reinforce the accuracy and reliability of its SET® pulse oximetry technology in one of the most…

Read MoreMasimo SET® Pulse Oximetry Shows Accurate Performance Across All Newborn Skin Tones in Landmark Study

CareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing

CareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing CareDx, Inc., widely recognized for its focus on advancing precision medicine solutions in transplant care, has taken a significant strategic step to broaden its reach into oncology diagnostics.…

Read MoreCareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing

Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler to Enhance Patient Access and Navigation

Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler, Enhancing Patient Access and Transparency The Global Healthy Living Foundation (GHLF) has announced a new collaboration with Walgreens aimed at simplifying how adults across the United States access vaccines. At the…

Read MoreGlobal Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler to Enhance Patient Access and Navigation

AIDS Healthcare Foundation Pushes Gilead Sciences for Greater Patent Transparency

AIDS Healthcare Foundation Files Shareholder Proposal Urging Gilead Sciences to Increase Transparency on Patent Exclusivity Practices Access to life-saving medicines remains one of the most critical challenges in global healthcare, and for many advocates, the issue extends far beyond scientific…

Read MoreAIDS Healthcare Foundation Pushes Gilead Sciences for Greater Patent Transparency

Prothena Announces Novo Nordisk Secures FDA Fast Track Status for Coramitug (PRX004)

Prothena Reports U.S. Food and Drug Administration Grants Fast Track Status to Coramitug (PRX004) for ATTR Cardiomyopathy, Secured by Novo Nordisk Prothena Corporation plc has announced a key regulatory development for coramitug, an investigational therapy being advanced for the treatment…

Read MoreProthena Announces Novo Nordisk Secures FDA Fast Track Status for Coramitug (PRX004)

Evofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa

Evofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa Evofem Biosciences, Inc., a biopharmaceutical company focused on advancing innovative solutions for women’s health, has announced a strategic step to expand global access to its flagship anti-infective therapy.…

Read MoreEvofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa

WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives

WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural completion of its new microbial commercial manufacturing facility in Chengdu,…

Read MoreWuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives